Effects of Concomitant Medication Use on Gefitinib-Induced Hepatotoxicity
Author:
Affiliation:
1. College of Pharmacy & Division of Life and Pharmaceutical Sciences; Ewha Womans University; Seoul Republic of Korea
2. Department of Pharmacy; Asan Medical Center; Seoul Republic of Korea
Publisher
Wiley
Subject
Pharmacology (medical),Pharmacology
Reference22 articles.
1. KOSIS Korean Statistical Information Service 1999-2014
2. Non-small cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow up;D'Addario;Ann Oncol,2009
3. Gefitinib or chemotherapy for non-small cell lung cancer with mutated EGFR.;Maemondo;N Engl J Med,2010
4. Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomized phase 3 tiral;Mitsudomi;Lancet Oncol,2010
5. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma;Mok;N Engl J Med,2009
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Anticancer Activity of Mannose-Specific Lectin, BPL2, from Marine Green Alga Bryopsis plumosa;Marine Drugs;2022-12-13
2. Evaluation of factors affecting epidermal growth factor receptor tyrosine kinase inhibitor-induced hepatotoxicity in Japanese patients with non-small cell lung cancer: a two-center retrospective study;Journal of Pharmaceutical Health Care and Sciences;2022-12-01
3. Impact of the Gastric Acid Suppressant Use on the Safety and Effectiveness of EGFR-TKIs: A Systematic Review and Meta-Analysis;Frontiers in Pharmacology;2022-06-20
4. The association between proton pump inhibitor use and systemic anti‐tumour therapy on survival outcomes in patients with advanced non‐small cell lung cancer: A systematic review and meta‐analysis;British Journal of Clinical Pharmacology;2022-03-08
5. A Risk Scoring System Utilizing Machine Learning Methods for Hepatotoxicity Prediction One Year After the Initiation of Tyrosine Kinase Inhibitors;Frontiers in Oncology;2022-03-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3